KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $192.0 million.

  • AbbVie's Depreciation & Amortization (CF) rose 52.36% to $192.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $765.0 million, marking a year-over-year increase of 268.46%. This contributed to the annual value of $764.0 million for FY2024, which is 159.57% up from last year.
  • According to the latest figures from Q3 2025, AbbVie's Depreciation & Amortization (CF) is $192.0 million, which was up 52.36% from $186.0 million recorded in Q2 2025.
  • AbbVie's Depreciation & Amortization (CF)'s 5-year high stood at $223.0 million during Q3 2021, with a 5-year trough of $173.0 million in Q4 2021.
  • Over the past 5 years, AbbVie's median Depreciation & Amortization (CF) value was $191.0 million (recorded in 2024), while the average stood at $192.4 million.
  • Examining YoY changes over the last 5 years, AbbVie's Depreciation & Amortization (CF) showed a top increase of 7913.04% in 2021 and a maximum decrease of 2378.85% in 2021.
  • Quarter analysis of 5 years shows AbbVie's Depreciation & Amortization (CF) stood at $173.0 million in 2021, then grew by 13.29% to $196.0 million in 2022, then fell by 4.59% to $187.0 million in 2023, then grew by 10.16% to $206.0 million in 2024, then decreased by 6.8% to $192.0 million in 2025.
  • Its last three reported values are $192.0 million in Q3 2025, $186.0 million for Q2 2025, and $181.0 million during Q1 2025.